期刊文献+

我院2006~2009年抗糖尿病药物用药分析 被引量:2

Utilization of Antidiabetics in Our Hospital During the Period 2006~2009
下载PDF
导出
摘要 目的评价我院2006-2009年抗糖尿病药应用状况。方法对2006-2009年抗糖尿病药的用药金额和用药频度(DDDs)进行统计。结果抗糖尿病药用药金额逐年增长。其中,胰岛素用药金额的增长快于口服抗糖尿病药。口服抗糖尿病药以磺酰脲类为主。按照DDDs排序,格列吡嗪是临床最常用的口服抗糖尿病药。结论我院抗糖尿病药物应用基本稳定、合理。 Objective To analyze the utilization of antidiabetics in our hospital during the period 2006-2008.Methods The consumption sum and DDDs of the antidiabetics in our hospital during the period 2006-2008 were investigated.Results The consumption sum of antidiabetics increased year by year,with that of insulin showing faster increase than that of oral antidiabetics.Sulfonylurea take the lead among all the oral antidiabetics.Glipizide dominated the first place on the list of DDDs in the clinic.Conclusion The utilization of antidiabetics in our hospital during the period 2006-2008 is basically stable and reasonable.
出处 《中国药事》 CAS 2011年第5期515-516,519,共3页 Chinese Pharmaceutical Affairs
关键词 抗糖尿病药 限定日剂量 用药分析 antidiabetics defined daily dose(DDD) analysis of drug use
  • 相关文献

参考文献7

二级参考文献38

  • 1韦劲.我院口服降糖药的药物利用分析[J].中国药师,2004,7(12):961-962. 被引量:2
  • 2邹豪,邵元福,朱才娟,邓渝林,马玉杰,陈盛新.医院药品DDD数排序分析的原理及利用[J].中国药房,1996,7(5):215-217. 被引量:1426
  • 3吴庆欢,杨鸿,伍俊妍,陈彩云,郑翠,马凌燕.广州地区36家医院2003~2005年降糖药利用分析[J].中国药房,2007,18(11):814-816. 被引量:14
  • 4Raymn G.Insulisime provides superior postprandial glucose control with less noctural hypoglycaemia is compared with regular human insulin in subjects with type 2 diabetes[J].Diabetologia,2005,48(suppl 7):44. 被引量:1
  • 5Standl E,Maxeiner S,Raptis S.Once-daily insulin glargine administration in the morning compared to bedtime in combination with morning glimepiride in patients with type 2 diabetes:an assessment of treatment flexibility[J].Horm Metab Res,2006,38(3):172-177. 被引量:1
  • 6Rosenstock J,Schwartz SL,Clark CM Jr,et al.Basal insulin therapy in type 2 diabetes:28-week comparison of insulin glargine (HOE 901) and NPH insulin[J].Diabetes Care,2001,24(4):631-636. 被引量:1
  • 7Leeuw I,Vague P,Selam JL,et al.Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin[J].Diabetes Obes Metab,2005,7(1):73-82. 被引量:1
  • 8Niskanen L,Jensen LE,Rastam J,et al.Randomized,multinational,open-label,2-period,crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus[J].Clin Ther,2004,26(4):531-540. 被引量:1
  • 9Hermansen K,Colombo M,Storgaard H,et al.Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes[J].Diabetes Care,2002,25(5):883-888. 被引量:1
  • 10Raskin P,Allen E,Hollander P,et al.Initiating insulin therapy in type 2 Diabetes:a comparison of biphasic and basal insulin analogs[J].Diabetes Care,2005,28(2):260-265. 被引量:1

共引文献67

同被引文献9

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部